PeptideGrids

FDA 503B outsourcing facilities in California

California has 7 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 4 with FDA drug recalls on record, the earliest registered in 2014. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.

FacilityCityFDA-registered sinceFDA recalls
McGuff Pharmaceuticals, Inc. dba McGuff Outsourcing Solutions Santa Ana 2023 4
Vitae Enim Vitae Scientific, Inc. San Diego 2024 4
Nivagen Pharmaceuticals, LLC Sacramento 2026 1
Nubratori, Inc. Torrance 2017 1
MedisourceRx Los Alamitos 2017 None on record
Wedgewood Connect, LLC, formerly registered as Leiter's Compounding San Jose 2014 None on record
Xseer Pharmaceuticals, Inc. Los Angeles 2023 None on record

503B compounding in California

A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in California must hold the appropriate state pharmacy license. Verify any facility's current license with the California State Board of Pharmacy.

Peptides and GLP-1s compounded in California

Facilities in California report compounding Glutathione, Semaglutide to the FDA. PeptideGrids grades the clinical evidence for each. Browse the full GLP-1 and therapeutic peptide databases.

Frequently asked questions

How many FDA 503B outsourcing facilities are in California?

7 FDA-registered 503B outsourcing facilities are listed in California on PeptideGrids, the earliest registered in 2014.

Which California 503B facilities have FDA recalls on record?

4 of the 7 California facilities have FDA drug recalls on record; the table above shows the count per facility.

How do I verify a pharmacy license in California?

Use the California State Board of Pharmacy license lookup to confirm a facility's current license status.

Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.